Troy Wilson, Kura Oncology CEO
June 14, 2023 11:00 AM EDT
R&D

Ku­ra plans to sell $100M of shares on the back of in­ter­im read­out of acute myeloid leukemia drug

Lei Lei Wu

News Reporter

Ku­ra On­col­o­gy in­tends to raise $100 mil­lion by sell­ing shares, it an­nounced Tues­day af­ter­noon. The stock sale comes af­ter the San …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Why did Eli Lil­ly ask a pa­tient on a com­pound­ed GLP-1 drug for their med­ical in­for­ma­tion?

FDA OKs the first-ever self-ad­min­is­tered vac­cine, for flu

The drug lob­by's law­suit against the IRA finds a sign of life af­ter ap­peals court rul­ing

Biotech VC firm out­lines plans for $100M fund

FTC to sue ma­jor PBMs over in­sulin re­bates, claim­ing they in­flat­ed pa­tient cost

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times